{"id":62885,"title":"IPI-145 shows promise in CLL patients.","abstract":"Results from a phase I study of Infinity Pharmaceuticals' IPI-145, which inhibits both ? and ? isoforms of phosphoinositide3-kinase, suggest the drug is safe and effective in patients with advanced chronic lymphocytic leukemia. ","date":"2014-02-06","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24501284","annotations":[{"name":"B-cell chronic lymphocytic leukemia","weight":0.850803,"wikipedia_article":"http://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia"},{"name":"Leukemia","weight":0.841184,"wikipedia_article":"http://en.wikipedia.org/wiki/Leukemia"},{"name":"Enzyme inhibitor","weight":0.77821,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Drug","weight":0.728515,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug"},{"name":"Clinical trial","weight":0.723286,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Lymphocyte","weight":0.721577,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphocyte"},{"name":"Protein isoform","weight":0.701037,"wikipedia_article":"http://en.wikipedia.org/wiki/Protein_isoform"},{"name":"Pharmaceutical drug","weight":0.678276,"wikipedia_article":"http://en.wikipedia.org/wiki/Pharmaceutical_drug"},{"name":"Chronic (medicine)","weight":0.660386,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Kinase","weight":0.424899,"wikipedia_article":"http://en.wikipedia.org/wiki/Kinase"},{"name":"Phosphoinositide","weight":0.0290048,"wikipedia_article":"http://en.wikipedia.org/wiki/Phosphoinositide"},{"name":"Phase (waves)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Phase_(waves)"}]}
